Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

545
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
545

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Efficacy and mechanism of Xiaoxuming Decoction on neurological function impairment in mice with cerebral ischemia-reperfusion based on metabolomics].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

[Interpretation of connotations of formula and syndrome of Chaihu Guizhi Decoction based on modern pathophysiological mechanisms and its clinical application].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

[Recognition and treatment of coronary microcirculation dysfunction with TCM].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

[Traditional Chinese medicine understanding and treatment strategy of carotid atherosclerotic plaque with hyperlipidemia].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

Deciphering the NEK7-NLRP3 inflammasome assembly: from conformational activation to allosteric drug discovery.

Frontiers in immunology·2026
Same author

[Efficacy and safety of Wenxin Granules in treating chronic pulmonary heart disease complicated by arrhythmia: a systematic review and Meta-analysis].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026

Related Experiment Video

Updated: Jan 6, 2026

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

435

Risk Factors for Severity of Adverse Events Associated with Xuebijing Injection: A Propensity Score-Matched Analysis.

Rui Zheng1, Zhuo Chen1, Xiao-Ying Zhong1

  • 1Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.

Chinese Journal of Integrative Medicine
|November 18, 2025
PubMed
Summary

Age, gender, allergies, and combining Xuebijing Injection (XBJ) with other β-lactam antimicrobials are key risk factors for severe adverse events (AEs). Careful clinical consideration of these factors, especially XBJ-β-lactam combinations, is crucial for patient safety.

Keywords:
Xuebijing Injectionadverse eventother β-lactam antimicrobialspropensity score-matched analysisrisk factorsafety

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K
Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
05:19

Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension

Published on: September 1, 2023

2.0K

Related Experiment Videos

Last Updated: Jan 6, 2026

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

435
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K
Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
05:19

Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension

Published on: September 1, 2023

2.0K

Area of Science:

  • Pharmacovigilance
  • Drug Safety
  • Clinical Pharmacology

Background:

  • Xuebijing Injection (XBJ) is a widely used traditional Chinese medicine injection.
  • Understanding risk factors for XBJ-related adverse events (AEs) is crucial for safe clinical practice.

Purpose of the Study:

  • To identify and analyze risk factors associated with the severity of XBJ-related adverse events (AEs).

Main Methods:

  • Retrospective analysis of 16,031 XBJ-related AE cases from China's spontaneous reporting system (2004-2022).
  • Examination of factors including age, gender, weight, ethnicity, family history, and allergic history.
  • Application of univariate, multivariate logistic regression, and propensity score matching (PSM) for robust analysis.

Main Results:

  • 11,131 valid XBJ-related AE cases were analyzed, with 1,360 classified as serious.
  • Serious AEs predominantly affected the respiratory, thoracic, and mediastinal systems (27%).
  • Age, gender, allergy history, and combination with β-lactam antimicrobials were identified as significant risk factors for severe AEs, with PSM confirming a higher risk (OR=1.913) for XBJ-β-lactam combinations.

Conclusions:

  • Age, gender, allergy history, and concurrent use of XBJ with β-lactam antimicrobials are significant risk factors for severe AEs.
  • The combination of XBJ with other β-lactam antimicrobials warrants particular attention in clinical settings due to increased risk of severe adverse events.